157 related articles for article (PubMed ID: 26160286)
1. Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats.
Cezar MD; Damatto RL; Pagan LU; Lima AR; Martinez PF; Bonomo C; Rosa CM; Campos DH; Cicogna AC; Gomes MJ; Oliveira SA; Blotta DA; Okoshi MP; Okoshi K
Cell Physiol Biochem; 2015; 36(4):1453-66. PubMed ID: 26160286
[TBL] [Abstract][Full Text] [Related]
2. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
Brilla CG; Matsubara L; Weber KT
Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
[TBL] [Abstract][Full Text] [Related]
3. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats.
Benetos A; Lacolley P; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1152-6. PubMed ID: 9194767
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
Tsotetsi OJ; Woodiwiss AJ; Netjhardt M; Qubu D; Brooksbank R; Norton GR
Hypertension; 2001 Oct; 38(4):846-51. PubMed ID: 11641297
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat.
Conrad CH; Brooks WW; Hayes JA; Sen S; Robinson KG; Bing OH
Circulation; 1995 Jan; 91(1):161-70. PubMed ID: 7805198
[TBL] [Abstract][Full Text] [Related]
7. Effects of treppe and calcium on intracellular calcium and function in the failing heart from the spontaneously hypertensive rat.
Brooks WW; Bing OH; Litwin SE; Conrad CH; Morgan JP
Hypertension; 1994 Sep; 24(3):347-56. PubMed ID: 8082941
[TBL] [Abstract][Full Text] [Related]
8. Relative systolic dysfunction in female spontaneously hypertensive rat myocardium.
Renna BF; MacDonnell SM; Reger PO; Crabbe DL; Houser SR; Libonati JR
J Appl Physiol (1985); 2007 Jul; 103(1):353-8. PubMed ID: 17431084
[TBL] [Abstract][Full Text] [Related]
9. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure.
Boluyt MO; Bing OH; Lakatta EG
Eur Heart J; 1995 Dec; 16 Suppl N():19-30. PubMed ID: 8682057
[TBL] [Abstract][Full Text] [Related]
10. Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine.
Campbell SE; Turek Z; Rakusan K; Kazda S
Cardiovasc Res; 1993 Jul; 27(7):1350-8. PubMed ID: 8252599
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.
Cingolani OH; Yang XP; Liu YH; Villanueva M; Rhaleb NE; Carretero OA
Hypertension; 2004 May; 43(5):1067-73. PubMed ID: 15023934
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.
Brooks WW; Bing OH; Robinson KG; Slawsky MT; Chaletsky DM; Conrad CH
Circulation; 1997 Dec; 96(11):4002-10. PubMed ID: 9403625
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of colchicine on myocardial function: studies in hypertrophied and failing spontaneously hypertensive rats.
Cicogna AC; Robinson KG; Conrad CH; Singh K; Squire R; Okoshi MP; Bing OH
Hypertension; 1999 Jan; 33(1):60-5. PubMed ID: 9931082
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.
Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR
Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural changes during myocardial hypertrophy and its regression: long-term effects of nifedipine in adult spontaneously hypertensive rats.
Kimpara T; Okabe M; Nishimura H; Hayashi T; Imamura K; Kawamura K
Heart Vessels; 1997; 12(3):143-51. PubMed ID: 9496465
[TBL] [Abstract][Full Text] [Related]
16. Myocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study.
Pereira LM; Mandarim-de-Lacerda CA
J Cell Mol Med; 2002; 6(1):49-57. PubMed ID: 12003668
[TBL] [Abstract][Full Text] [Related]
17. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure.
Bing OH; Brooks WW; Robinson KG; Slawsky MT; Hayes JA; Litwin SE; Sen S; Conrad CH
J Mol Cell Cardiol; 1995 Jan; 27(1):383-96. PubMed ID: 7760360
[TBL] [Abstract][Full Text] [Related]
18. Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats.
Cingolani OH; Yang XP; Cavasin MA; Carretero OA
Hypertension; 2003 Feb; 41(2):249-54. PubMed ID: 12574090
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.
Rigsby CS; Pollock DM; Dorrance AM
Microvasc Res; 2007 May; 73(3):198-205. PubMed ID: 17250855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
